UNICYCIVE THERAPEUTICS, INC. Prepaid Expense Other, Noncurrent
UNICYCIVE THERAPEUTICS, INC. (UNCY) had Prepaid Expense Other, Noncurrent of $2.80 million as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:PrepaidExpenseOtherNoncurrent · last filed 2025-05-14
- 2025-03-31: Prepaid Expense Other, Noncurrent $2.80M.
- 2024-12-31: Prepaid Expense Other, Noncurrent $2.80M.
- 2023-12-31: Prepaid Expense Other, Noncurrent $600.00K.
- 2023-09-30: Prepaid Expense Other, Noncurrent $900.00K.
| Period end | Prepaid Expense Other, Noncurrent |
|---|---|
| 2025-03-31 | $2.80M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $2.80M 10-K · filed 2025-03-31 |
| 2023-12-31 | $600.00K 10-K · filed 2024-03-28 |
| 2023-09-30 | $900.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.00M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.00M 10-Q · filed 2023-05-16 |
| 2022-12-31 | $1.00M 10-K · filed 2023-03-31 |
| 2022-09-30 | $800.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |